Dr. Simone Hettmer
Simone is a pediatric oncology physician-scientist with a special interest in rhabdomyosarcoma. She was born in the Stuttgart area and raised in the South-West of Germany. She studied medicine at the University of Tuebingen and investigated the role of insulin-like growth factor binding proteins in leukemia as part of her doctoral thesis.
After 1.5 years of clinical training in pediatrics at the University of Bonn, a research award by the German Cancer Foundation took Simone to George Washington University in Washington D.C. There, she studied glycolipid metabolism in neuroblastoma in the lab of Stephan Ladisch. After a pediatric residency at the Massachusetts General Hospital, Simone joined the fellowship program at Dana-Farber/Boston Children’s Hospital Center for Cancer and Blood Disorders. She did her research training with Dr. Amy Wagers at the Harvard Stem Cell Institute and published several research papers on mouse models of soft-tissue sarcoma and skeletal muscle stem cell biology.
She recently returned to Germany and joined the pediatric hematology/oncology department at the Charité in Berlin.
In this program, Dr. Hettmer discussed the current state of rhabdo treatment and where, as a clinician/researcher, she sees it headed.